Christine L. Zimmer
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.
Journal: The British journal of dermatology
Published: March 12, 2025
Deep Analysis of Desmoglein-3-Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature.
Journal: The Journal of investigative dermatology
Published: January 06, 2025
Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research.
Journal: Frontiers in immunology
Published: July 15, 2024
A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 13, 2024
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus Vulgaris.
Journal: The Journal of investigative dermatology
Published: November 08, 2022
Isolation of Lymphocytes from Human Skin and Murine Tissues: A Rapid and Epitope-Preserving Approach.
Journal: JID innovations : skin science from molecules to population health
Published: December 15, 2021
Detection of autoreactive CD4+ T cells by MHC class II multimers in HLA-linked human autoimmune diseases.
Journal: The Journal of clinical investigation
Published: May 03, 2021
Pemphigus: a critical analysis on clinical subtypes, pathogenesis, diagnostics and established novel therapeutics.
Journal: Italian journal of dermatology and venereology
Published: December 14, 2020
Immune serological diagnosis of pemphigus.
Journal: Italian journal of dermatology and venereology
Published: November 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026